Inventor · disambiguated record
Marck Norret
Also filed as: NORRET MARCK
20 granted patents·51 pending applications·99 citations·filing 2003–2024
95Inventor score
Top patents by PatentIndex Score
71 records- 0195US9095496B2Formulation of indomethacinICEUTICA PTY LTD·Filed 2014·Granted Aug 4, 2015·13 cites·18 claims
- 0294US9089471B2Formulation of indomethacinICEUTICA PTY LTD·Filed 2014·Granted Jul 28, 2015·9 cites·28 claims
- 0394US8734847B2Formulation of indomethacinICEUTICA INC·Filed 2013·Granted May 27, 2014·10 cites·22 claims
- 0492US8992982B2Formulation of indomethacinICEUTICA PTY LTD·Filed 2014·Granted Mar 31, 2015·5 cites·30 claims
- 0592US2024390871A1Production of encapsulated nanoparticles at high volume fractionsICEUTICA PTY LTD·Filed 2024·Application pending·0 cites
- 0690US9186328B2Formulation of diclofenacICEUTICA PTY LTD·Filed 2015·Granted Nov 17, 2015·5 cites·30 claims
- 0790US9180096B2Formulation of diclofenacICEUTICA PTY LTD·Filed 2015·Granted Nov 10, 2015·5 cites·30 claims
- 0890US9173854B2Formulation of diclofenacICEUTICA PTY LTD·Filed 2015·Granted Nov 3, 2015·5 cites·30 claims
- 0989US9849111B2Formulation of indomethacinICEUTICA PTY LTD·Filed 2016·Granted Dec 26, 2017·2 cites·19 claims
- 1089US8735450B2Formulation of diclofenacDODD AARON·Filed 2010·Granted May 27, 2014·12 cites·18 claims
- 1189US2025049720A1Method for improving the dissolution profile of a biologically active materialICEUTICA PTY LTD·Filed 2024·Application pending·0 cites
- 1287US10292990B2Abiraterone steroid formulationSUN PHARMA GLOBAL FZE·Filed 2016·Granted May 21, 2019·4 cites·2 claims
- 1387US9017721B2Formulation of diclofenacICEUTICA PTY LTD·Filed 2014·Granted Apr 28, 2015·5 cites·24 claims
- 1487US8999387B2Formulation of diclofenacICEUTICA PTY LTD·Filed 2014·Granted Apr 7, 2015·5 cites·24 claims
- 1587US8679544B2Formulation of diclofenacICEUTICA INC·Filed 2013·Granted Mar 25, 2014·6 cites·24 claims
- 1686US9889144B2Abiraterone acetate formulation and methods of useICEUTICA INC·Filed 2017·Granted Feb 13, 2018·5 cites·20 claims
- 1785US10022303B2Inhalable pharmaceutical compositionsBOSCH H WILLIAM·Filed 2013·Granted Jul 17, 2018·4 cites·8 claims
- 1885US2023356232A1Production of encapsulated nanoparticles at commercial scaleICEUTICA PTY LTD·Filed 2023·Application pending·0 cites
- 1982US2020375903A1Method for improving the dissolution profile of a biologically active materialICEUTICA PTY LTD·Filed 2019·Application pending·0 cites
- 2082US2023128622A1Novel formulation of meloxicamICEUTICA PTY LTD·Filed 2022·Application pending·0 cites
- 2180US9522135B2Formulation of indomethacinICEUTICA PTY LTD·Filed 2015·Granted Dec 20, 2016·1 cites·26 claims
- 2280US2023133244A1Method for the Production of Commercial Nanoparticle and Microparticle PowdersICEUTICA PTY LTD·Filed 2022·Application pending·0 cites
- 2379US10172828B2Formulation of indomethacinICEUTICA PTY LTD·Filed 2017·Granted Jan 8, 2019·1 cites·19 claims
- 2479US2021401753A1Method for improving the dissolution profile of a biologically active materialICEUTICA PTY LTD·Filed 2021·Application pending·0 cites
- 2576US2021260598A1Production of encapsulated nanoparticles at commercial scaleICEUTICA PTY LTD·Filed 2021·Application pending·0 cites
- 2676US2021403442A1Novel formulation of metaxaloneICEUTICA PTY LTD·Filed 2021·Application pending·0 cites
- 2772US2021002267A1Novel formulation of meloxicamICEUTICA PTY LTD·Filed 2020·Application pending·0 cites
- 2871US2020308123A1Novel formulation of metaxaloneICEUTICA PTY LTD·Filed 2020·Application pending·0 cites
- 2970US2020316546A1Production of encapsulated nanoparticles at high volume fractionsICEUTICA PTY LTD·Filed 2020·Application pending·0 cites
- 3070US2020390710A1Method for the Production of Commercial Nanoparticle and Microparticle PowdersICEUTICA PTY LTD·Filed 2020·Application pending·0 cites
- 3170US2018243707A1Production of encapsulated nanoparticles at high volume fractionsICEUTICA PTY LTD·Filed 2018·Application pending·0 cites
- 3270US2018296514A1Novel formulation of diclofenacICEUTICA PTY LTD·Filed 2018·Application pending·0 cites
- 3368US2019193085A1Production of encapsulated nanoparticles at commercial scaleICEUTICA PTY LTD·Filed 2019·Application pending·0 cites
- 3468US2017320030A1Production of encapsulated nanoparticles at high volume fractionsICEUTICA PTY LTD·Filed 2017·Application pending·0 cites
- 3566US2018251433A1Novel formulation of metaxaloneICEUTICA PTY LTD·Filed 2018·Application pending·0 cites
- 3666US2015209796A1Production of encapsulated nanoparticles at commercial scaleICEUTICA PTY LTD·Filed 2014·Application pending·0 cites
- 3765US2017100356A1Novel formulation of diclofenacICEUTICA PTY LTD·Filed 2016·Application pending·0 cites
- 3864US2014302127A1Novel formulation of metaxaloneICEUTICA PTY LTD·Filed 2014·Application pending·0 cites
- 3964US2018194759A1Novel formulation of meloxicamICEUTICA PTY LTD·Filed 2018·Application pending·0 cites
- 4064US2018169662A1Production of encapsulated nanoparticles at commercial scaleICEUTICA PTY LTD·Filed 2017·Application pending·0 cites
- 4163US2014326812A1Method for the Production of Commercial Nanoparticle and Microparticle PowdersICEUTICA PTY LTD·Filed 2014·Application pending·0 cites
- 4263US2015087709A1Novel Formulation of NaproxenICEUTICA INC·Filed 2014·Application pending·0 cites
- 4363US2015306556A1Production of encapsulated nanoparticles at high volume fractionsICEUTICA PTY LTD·Filed 2015·Application pending·0 cites
- 4463US2014199395A1Novel formulation of meloxicamICEUTICA PTY LTD·Filed 2013·Application pending·0 cites
- 4563US2018009769A1Novel formulation of metaxaloneICEUTICA PTY LTD·Filed 2017·Application pending·0 cites
- 4663US2018169018A1Method for improving the dissolution profile of a biologically active materialICEUTICA PTY LTD·Filed 2018·Application pending·0 cites
- 4762US2016067199A1Novel formulation of diclofenacICEUTICA PTY LTD·Filed 2015·Application pending·0 cites
- 4862US2016058707A1Novel formulation of diclofenacICEUTICA PTY LTD·Filed 2015·Application pending·0 cites
- 4961US9180095B2Formulation of diclofenacICEUTICA PTY LTD·Filed 2015·Granted Nov 10, 2015·0 cites·30 claims
- 5061US2013277468A1Method for improving the dissolution profile of a biologically active materialICEUTICA INC·Filed 2013·Application pending·0 cites
Showing the top 50 of 71 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Marck Norret files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →